Trial intelligence / Profile preview

Levetiracetam vs phenobarbital as first-line treatment for neonatal seizures

IRCT20220410054471N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2019
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of levetiracetam and phenobarbital in seizure (2 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

levetiracetamphenobarbital
03

Conditions

seizure

Beyond the preview

Go deeper on IRCT20220410054471N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220410054471N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call